By Kelly Prifti, project manager - GO
NIH grants are preceded by a letter and a number to clarify the type of funding mechanism used. This article will explain the most common types of grants open to researchers at Institut Pasteur.
The National Institutes of Health (NIH) is the primary agency of the United States government responsible for biomedical and public health research.
The NIH is the largest public funder of biomedical research in the world, investing more than $45 billion a year to enhance life, and reduce illness and disability for the American people.
There are many funding mechanisms, among the most common:
“R” for “Research Grants”
R21 NIH Exploratory/Developmental Research Grant Program provides support for the early and conceptual stages of research projects. The R21 program allows for 2 years of support and $275,000 over those years.
R01 The original and historically oldest grant mechanism used by NIH. The R01 provides support for health-related research and development based on the mission of the NIH. Permits larger, longer, more ambitious projects than the R21.
“U” Projects
U Projects are technically not grants, they are “cooperative agreements.” They function similarly to grants but imply substantial programmatic involvement by the funding agency.
U01 supports high-priority research projects to be performed by investigator(s) in an area representing their specific interests and competencies. No specific dollar limit unless specified in funding opportunity.
R21 and R01 opportunities usually offer three due dates per year whereas the U series are usually open only to one deadline.
Read more here.
Contact the GO International Division to find out which type of grant is best for your project.
Comments